What is NKTX (NKTX) stock price today?

NKTX (NKTX) is currently trading at $2.41, up 5.24% today.

What is NKTX P/E ratio?

NKTX's P/E ratio is -1.97. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is NKTX return on equity (ROE)?

NKTX's return on equity (ROE) is -33.33%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is NKTX's market cap?

NKTX has a market capitalization of $172.42M.

NASDAQ · Biotechnology

NKTX (NKTX) Stock

$2.41 +5.24% NASDAQ: NKTX Healthcare

Valuation

Metric	Value
Price	$2.41
Market Cap	$172.42M
P/E Ratio	-1.97
P/B Ratio	0.64
P/S Ratio	0.00
EPS (TTM)	$-1.41
52-Week High	$3.67
52-Week Low	$1.63
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-33.33%
ROA	-25.74%
ROCE	-38.78%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.26
Current Ratio	12.86

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$0	$0	$0
Operating Profit	$-86.0M	$-119.0M	$-132.0M	$-128.0M	$-121.0M
Net Profit	$-86.0M	$-114.0M	$-118.0M	$-109.0M	$-104.0M
EPS	$-2.62	$-2.61	$-2.40	$-1.60	$-1.41
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$274.0M	$473.0M	$379.0M	$501.0M	$404.0M
Total Liabilities	$23.0M	$101.0M	$106.0M	$93.0M	$92.0M
Cash	$61.0M	$37.0M	$31.0M	$28.0M	$40.0M
Borrowings	$12.0M	$83.0M	$88.0M	$80.0M	$76.0M

Latest News

Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference GlobeNewswire · Jun 26, 2026 TD Cowen Initiates Nkarta at Buy MT Newswires · Jun 23, 2026 Here's Why We're Not Too Worried About Nkarta's (NASDAQ:NKTX) Cash Burn Situation Simply Wall St. · May 14, 2026 Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights GlobeNewswire · May 12, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-68.0M	$-57.0M	$-86.0M	$-100.0M	$-89.0M
Investing Cash Flow	$28.0M	$-232.0M	$51.0M	$-134.0M	$99.0M
Financing Cash Flow	$0	$2.0M	$0	$1.0M	$0
Net Cash Flow	$-34.0M	$-23.0M	$-6.0M	$-3.0M	$12.0M
Free Cash Flow	$-73.0M	$-104.0M	$-114.0M	$-104.0M	$-90.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	-40.73%
Quick Ratio	12.96
Interest Coverage	—
Return 1Y	40.21%
Return 3Y	33.17%
Return 5Y	-91.16%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$313.33	+0.29%	37.72	$4.60T	0.34%
MSFTMicrosoft Corporation	$499.99	+0.03%	22.95	$3.71T	0.94%
GOOGLAlphabet Inc.	$354.30	-0.96%	27.68	$4.29T	0.23%
AMZNAmazon.com, Inc.	$274.48	+0.82%	28.76	$2.95T	0.00%
METAMeta Platforms, Inc.	$592.10	+0.37%	21.47	$1.51T	0.35%

About NKTX

NKTX is led by CEO Paul J. Hastings, publicly traded since 2020.

NKTX stock trades at $2.41 with a market capitalization of $172.42M. The stock is valued at a price-to-earnings (P/E) ratio of -1.97, price-to-book of 0.64, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.63 and $3.67, and currently trades 34.3% below its 52-week high.

On profitability, NKTX generates a return on equity (ROE) of -33.33%, return on capital employed of -38.78%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides